SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
May 24, 2010	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001424884-10-000064.pdf 0001424884-10-000064.rtf 0001424884-10-000064.xls View HTML
May 24, 2010	8-K	Report of unscheduled material events or corporate event	0001424884-10-000066.pdf 0001424884-10-000066.rtf 0001424884-10-000066.xls View HTML
May 18, 2010	8-K	Report of unscheduled material events or corporate event	0001424884-10-000060.pdf 0001424884-10-000060.rtf 0001424884-10-000060.xls View HTML
May 17, 2010	NT 10-Q	Notification that form type 10-Q will be submitted late	0001424884-10-000049.pdf 0001424884-10-000049.rtf 0001424884-10-000049.xls View HTML
Apr 15, 2010	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001424884-10-000040.pdf 0001424884-10-000040.rtf 0001424884-10-000040.xls View HTML
Apr 1, 2010	NT 10-K	Notification that form 10-K will be submitted late	0001183740-10-000161.pdf 0001183740-10-000161.rtf 0001183740-10-000161.xls View HTML
Feb 26, 2010	8-K	Report of unscheduled material events or corporate event	0001424884-10-000030.pdf 0001424884-10-000030.rtf 0001424884-10-000030.xls View HTML
Feb 8, 2010	8-K	Report of unscheduled material events or corporate event	0001424884-10-000010.pdf 0001424884-10-000010.rtf 0001424884-10-000010.xls View HTML
Jan 29, 2010	DEF 14C	DEF 14C	0001424884-10-000008.pdf 0001424884-10-000008.rtf 0001424884-10-000008.xls View HTML
Jan 6, 2010	PRE 14C	A preliminary proxy statement containing all other information	0001424884-10-000002.pdf 0001424884-10-000002.rtf 0001424884-10-000002.xls View HTML

Data provided by Kaleidoscope.